APA (7th ed.) Citation

S, M., K, A. K., M, A., & M, D. (2026). An Engineered SARS-CoV-2 S1 Glycoprotein Produced in Pichia pastoris as a Candidate Vaccine Antigen. Molecular biotechnology, 68(2), 815. https://doi.org/10.1007/s12033-025-01409-5

Chicago Style (17th ed.) Citation

S, Majidi, Aghaiypour Kolyani K, Akrami M, and Dadar M. "An Engineered SARS-CoV-2 S1 Glycoprotein Produced in Pichia Pastoris as a Candidate Vaccine Antigen." Molecular Biotechnology 68, no. 2 (2026): 815. https://doi.org/10.1007/s12033-025-01409-5.

MLA (9th ed.) Citation

S, Majidi, et al. "An Engineered SARS-CoV-2 S1 Glycoprotein Produced in Pichia Pastoris as a Candidate Vaccine Antigen." Molecular Biotechnology, vol. 68, no. 2, 2026, p. 815, https://doi.org/10.1007/s12033-025-01409-5.